99mTc-MIBI in the evaluation of breast cancer biology

Silvana Del Vecchio; Antonella Zannetti; Rosa Fonti; Francesca Iommelli; Marco Salvatore

doi:10.1007/978-3-540-36781-9_7

^99mTc-MIBI in the evaluation of breast cancer biology

Silvana Del Vecchio, Antonella Zannetti, Rosa Fonti, Francesca Iommelli, Marco Salvatore

IRCCS SDN

Research output: Chapter in Book/Report/Conference proceeding › Chapter

Abstract

Scintigraphic in vivo evaluation of complex cellular processes such as proliferation, apoptosis, receptor/ligand interactions, transport of substrates and metabolism of nutrients in human cancers is a wide and continuing evolving area of investigation in nuclear medicine (Denoyer et al. 2006; Been et al. 2004; Corsten et al. 2006; Weissleder 2006). A major purpose in this area is the non-invasive detection of well-known biochemical, molecular and histological markers of tumor aggressiveness, invasiveness and resistance to therapy, which may provide rational criteria for a fine tuning of therapeutic strategies in individual patients.

Original language	English
Title of host publication	Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic Options
Publisher	Springer Berlin Heidelberg
Pages	71-81
Number of pages	11
ISBN (Print)	9783540367802
DOIs	https://doi.org/10.1007/978-3-540-36781-9_7
Publication status	Published - 2008

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1007/978-3-540-36781-9_7

Fingerprint Dive into the research topics of '<sup>99m</sup>Tc-MIBI in the evaluation of breast cancer biology'. Together they form a unique fingerprint.

Cite this

@inbook{684d150b3be8492f803e49e491e86d7b,

title = "99mTc-MIBI in the evaluation of breast cancer biology",

abstract = "Scintigraphic in vivo evaluation of complex cellular processes such as proliferation, apoptosis, receptor/ligand interactions, transport of substrates and metabolism of nutrients in human cancers is a wide and continuing evolving area of investigation in nuclear medicine (Denoyer et al. 2006; Been et al. 2004; Corsten et al. 2006; Weissleder 2006). A major purpose in this area is the non-invasive detection of well-known biochemical, molecular and histological markers of tumor aggressiveness, invasiveness and resistance to therapy, which may provide rational criteria for a fine tuning of therapeutic strategies in individual patients.",

author = "{Del Vecchio}, Silvana and Antonella Zannetti and Rosa Fonti and Francesca Iommelli and Marco Salvatore",

year = "2008",

doi = "10.1007/978-3-540-36781-9_7",

language = "English",

isbn = "9783540367802",

pages = "71--81",

booktitle = "Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic Options",

publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - 99mTc-MIBI in the evaluation of breast cancer biology

AU - Del Vecchio, Silvana

AU - Zannetti, Antonella

AU - Fonti, Rosa

AU - Iommelli, Francesca

AU - Salvatore, Marco

PY - 2008

Y1 - 2008

N2 - Scintigraphic in vivo evaluation of complex cellular processes such as proliferation, apoptosis, receptor/ligand interactions, transport of substrates and metabolism of nutrients in human cancers is a wide and continuing evolving area of investigation in nuclear medicine (Denoyer et al. 2006; Been et al. 2004; Corsten et al. 2006; Weissleder 2006). A major purpose in this area is the non-invasive detection of well-known biochemical, molecular and histological markers of tumor aggressiveness, invasiveness and resistance to therapy, which may provide rational criteria for a fine tuning of therapeutic strategies in individual patients.

AB - Scintigraphic in vivo evaluation of complex cellular processes such as proliferation, apoptosis, receptor/ligand interactions, transport of substrates and metabolism of nutrients in human cancers is a wide and continuing evolving area of investigation in nuclear medicine (Denoyer et al. 2006; Been et al. 2004; Corsten et al. 2006; Weissleder 2006). A major purpose in this area is the non-invasive detection of well-known biochemical, molecular and histological markers of tumor aggressiveness, invasiveness and resistance to therapy, which may provide rational criteria for a fine tuning of therapeutic strategies in individual patients.

UR - http://www.scopus.com/inward/record.url?scp=77955736262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955736262&partnerID=8YFLogxK

U2 - 10.1007/978-3-540-36781-9_7

DO - 10.1007/978-3-540-36781-9_7

M3 - Chapter

AN - SCOPUS:77955736262

SN - 9783540367802

SP - 71

EP - 81

BT - Breast Cancer: Nuclear Medicine in Diagnosis and Therapeutic Options

PB - Springer Berlin Heidelberg

ER -